Difference between revisions of "Part:BBa K1620007"

(→‎Usage and Biology)
(→‎Usage and Biology)
Line 16: Line 16:
 
</p>
 
</p>
  
−
[[File: Alignment between improved SmtA and BBa_K519010.jpg|450px|thumb|left|'''Figure 1:''' Improved SmtA (<partinfo>BBa_K1620007</partinfo>) compared to <partinfo>BBa_K519010</partinfo>; this new sequence is biobrick compatible due the removal of a PstI restriction site previously present in <partinfo>BBa_K519010</partinfo>.]]
+
[[File: Alignment between improved SmtA and BBa_K519010.jpg|450px|thumb|center|'''Figure 1:''' Improved SmtA (<partinfo>BBa_K1620007</partinfo>) compared to <partinfo>BBa_K519010</partinfo>; this new sequence is biobrick compatible due the removal of a PstI restriction site previously present in <partinfo>BBa_K519010</partinfo>.]]
  
 
<!-- -->
 
<!-- -->

Revision as of 22:06, 13 September 2015

Synechococcus metallothionenin A (SmtA)

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal AgeI site found at 121
  • 1000
    COMPATIBLE WITH RFC[1000]


Usage and Biology

SmtA is a metallothionein which bind to divalent metallic cations such as Zn(II). This SmtA was an improvement of the biobrick BBa_K519010 originally cloned from Synechococcus sp. PCC7942, a cyanobacterial strain. SmtA is a low cys content type II metallothionein. Other team (iGEM11_Tokyo-NoKoGen, 2011-09-30) have previously find SmtA constitutively expressed in E. coli improving its growth at a high Cd(II) concentrationwhen compared to wild type E. coli. This part was designed to eliminate an internal restriction site for PstI, the 98th base was changed G -> A. No residues were changed.

Figure 1: Improved SmtA (BBa_K1620007) compared to BBa_K519010; this new sequence is biobrick compatible due the removal of a PstI restriction site previously present in BBa_K519010.